Total Payments
$4,914
2024 Payments
$367.77
Companies
24
Transactions
247
Medicare Patients
21,491
Medicare Billing
$786,144
Payment Breakdown by Category
Food & Beverage$4,908 (99.9%)
Education$5.90 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,908 | 246 | 99.9% |
| Education | $5.90 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,840 | 87 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $1,118 | 52 | $0 (2024) |
| Lilly USA, LLC | $331.72 | 19 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $204.55 | 7 | $0 (2023) |
| Amarin Pharma Inc. | $193.91 | 8 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $175.02 | 13 | $0 (2021) |
| Phathom Pharmaceuticals, Inc. | $134.07 | 2 | $0 (2024) |
| Currax Pharmaceuticals LLC | $126.36 | 9 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $103.59 | 7 | $0 (2022) |
| GlaxoSmithKline, LLC. | $99.90 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $367.77 | 16 | Phathom Pharmaceuticals, Inc. ($134.07) |
| 2023 | $450.89 | 14 | AstraZeneca Pharmaceuticals LP ($309.32) |
| 2022 | $444.27 | 24 | Bayer HealthCare Pharmaceuticals Inc. ($153.50) |
| 2021 | $826.09 | 30 | Novo Nordisk Inc ($509.37) |
| 2020 | $693.21 | 44 | Novo Nordisk Inc ($312.29) |
| 2019 | $687.58 | 38 | Novo Nordisk Inc ($301.29) |
| 2018 | $548.45 | 42 | Novo Nordisk Inc ($266.68) |
| 2017 | $895.40 | 39 | Novo Nordisk Inc ($435.64) |
All Payment Transactions
247 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: RESPIRATORY | ||||||
| 08/28/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/06/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Diabetes | ||||||
| 07/15/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Diabetes Care | ||||||
| 07/09/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Respiratory | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: RESPIRATORY | ||||||
| 05/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Diabetes Care | ||||||
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Respiratory | ||||||
| 05/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Biological | ||||||
| 04/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Diabetes | ||||||
| 04/01/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Diabetes Care | ||||||
| 03/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $118.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/06/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Diabetes | ||||||
| 09/27/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/08/2023 | Currax Pharmaceuticals LLC | ONZETRA XSAIL (Drug), CONTRAVE | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Neurology | ||||||
| 06/21/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Cardio-renal | ||||||
| 06/15/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Respiratory | ||||||
| 05/17/2023 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Obesity | ||||||
| 05/09/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/04/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/26/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 44 | 5,675 | 10,758 | $869,166 | $184,889 |
| 2022 | 44 | 5,036 | 9,165 | $850,024 | $173,440 |
| 2021 | 46 | 5,802 | 9,532 | $975,588 | $250,145 |
| 2020 | 45 | 4,978 | 7,465 | $261,725 | $177,670 |
Total Patients
21,491
Total Services
36,920
Medicare Billing
$786,144
Procedure Codes
179
All Medicare Procedures & Services
179 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 301 | 772 | $323,013 | $38,826 | 12.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 145 | 263 | $78,080 | $12,908 | 16.5% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 91 | 92 | $40,884 | $10,060 | 24.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 277 | 765 | $30,730 | $9,999 | 32.5% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 112 | 227 | $28,112 | $9,182 | 32.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 282 | 803 | $25,439 | $8,292 | 32.6% |
| 83721 | Ldl cholesterol level | Office | 2023 | 277 | 763 | $24,035 | $7,823 | 32.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 287 | 850 | $7,650 | $7,115 | 93.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 226 | 375 | $18,900 | $6,156 | 32.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 100 | 104 | $60,812 | $5,852 | 9.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 67 | 67 | $14,753 | $4,819 | 32.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 114 | 162 | $14,386 | $4,700 | 32.7% |
| 83735 | Magnesium level | Office | 2023 | 275 | 713 | $14,331 | $4,666 | 32.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 270 | 601 | $14,009 | $4,574 | 32.6% |
| 86328 | Test for detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody, qualitative or semiquantitative | Office | 2023 | 100 | 102 | $13,856 | $4,526 | 32.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 152 | 414 | $12,060 | $3,923 | 32.5% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 207 | 260 | $11,762 | $3,843 | 32.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 142 | 155 | $14,187 | $3,575 | 25.2% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 260 | 533 | $9,658 | $3,139 | 32.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $9,481 | $3,112 | 32.8% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 104 | 120 | $9,292 | $3,013 | 32.4% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 108 | 205 | $8,382 | $2,714 | 32.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 70 | 70 | $7,279 | $2,378 | 32.7% |
| 84550 | Uric acid level, blood | Office | 2023 | 260 | 531 | $7,200 | $2,344 | 32.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 192 | 197 | $9,456 | $2,309 | 24.4% |
About Dr. Mark Rubinetti, M.D
Dr. Mark Rubinetti, M.D is a Internal Medicine healthcare provider based in Succasunna, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699705020.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Rubinetti, M.D has received a total of $4,914 in payments from pharmaceutical and medical device companies, with $367.77 received in 2024. These payments were reported across 247 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($4,908).
As a Medicare-enrolled provider, Rubinetti has provided services to 21,491 Medicare beneficiaries, totaling 36,920 services with total Medicare billing of $786,144. Data is available for 4 years (2020–2023), covering 179 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Succasunna, NJ
- Active Since 07/03/2006
- Last Updated 02/07/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1699705020
Products in Payments
- FARXIGA (Drug) $832.77
- Ozempic (Drug) $797.71
- RYBELSUS (Drug) $388.79
- Tresiba (Drug) $298.40
- Victoza (Drug) $290.95
- BREZTRI (Drug) $268.96
- Kerendia (Drug) $204.55
- Vascepa (Drug) $193.91
- JARDIANCE (Drug) $178.70
- TRULICITY (Drug) $168.71
- VOQUEZNA (Drug) $134.07
- JANUVIA (Drug) $132.29
- CONTRAVE (Drug) $98.28
- CINRYZE (Drug) $88.72
- NUEDEXTA (Drug) $57.84
- FREESTYLE LIBRE 3 (Device) $55.33
- TOUJEO (Drug) $50.01
- Haegarda (Biological) $47.66
- JANUMET (Drug) $42.73
- CREON (Drug) $42.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.